Do you have a type of #lymphoma called Waldenström’s macroglobulinemia? If you’ll be starting treatment, #clinicaltrial S2005 may be a treatment option for you. Learn more at SWOG.org/S2005 or 1-800-4-CANCER. #rarecancer #lymsm Jack Aiello IWMF

The Experimental Therapeutics Clinical Trials Network is conducting treatment trials for #sarcoma. Sarcoma is a type of cancer that begins in bone or in the soft tissues of the body. Learn more about #ETCTN sarcoma trials (pdf):buff.ly/2LN79F9 #SarcomaCancerAwarenessMonth

#Clinicaltrial EA9152, led by Neil Palmisiano, MD of Rutgers Cancer Institute, is investigating the safety & efficacy of venetoclax, a BCL-2 inhibitor, in combination with vincristine sulfate in the relapsed or refractory #ALL population. More: bit.ly/EA9152 #leusm cc: Acute Leukemia Advocates Network (ALAN)

#DYK Matt Galsky Icahn School of Medicine at Mount Sinai leads Alliance for Clinical Trials in Oncology A032103 (MODERN) to test the role of DNA released from tumor cells into the blood in guiding the use of #immunotherapy after bladder removal for #bladdercancer treatment: bit.ly/Alliance-A0321… @bladdercancerus Bladder Cancer

The 2024 Early Drug Development (EDD) meeting will be held on Sept., 26 – 27! This annual meeting enhances communication between National Cancer Institute and #ETCTN investigators that conduct #NCICTEP-sponsored trials. Registration (deadline is September 25): buff.ly/3tbKzMj rabih said

By analyzing DNA mutation patterns in kidney cancers from people globally, researchers found new clues about possible causes of the disease. Identifying these mutational signatures might lead to strategies for treating or even preventing #KidneyCancer. spr.ly/6013cMizT

EA1211/DIRECT aims to help doctors make better (more personalized) decisions around treatment for #patients with #HER2positive #BreastCancer. Consider learning more about this phase 2 #clinicaltrial if you have HER2-positive breast cancer. For more info: bit.ly/EA1211

A Closer Look at the Innovative Pragmatica-Lung Trial SWOG Cancer Research Network S2302 chair Karen Reckamp, MD, MS interviewed on streamlined phase 3 trial in #NSCLC w broader eligibility & lower site burden. Rewriting how we do oncology #ClinicalTrials. Lung-MAP NCI CTEP Clinical Research medpagetoday.com/meetingcoverag…

Newly Activated #NCTN #Lymphoma Trial: (S2308) Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma, led by SWOG Cancer Research Network Learn more: buff.ly/4dtszio

#ICYMI .Eric Miller The James leads Alliance for Clinical Trials in Oncology A022101/ERASur, a trial for patients w/metastatic #colorectalcancer that compares total ablative therapy & usual systemic therapy to usual systemic therapy alone: bit.ly/Alliance-A0221… #NCI #NCTN .Fight Colorectal Cancer .Colorectal Cancer Alliance

"This progress is only possible through clinical trials." #CancerResearch #EndCancerAsWeKnowIt. #NCTN clinical trial (E1910) ECOG-ACRIN Cancer Research Group Medical Xpress #NCICTEP. Read more: medicalxpress.com/news/2024-08-p…

#myeloMATCH substudies treat patients with #AML or #MDS sequentially from diagnosis thru all treatment stages. After each treatment, patients are rescreened for assignment to a substudy in another tier. National Cancer Institute @Alliance_org CCTG ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network swog.org/myeloMATCH

Could chemotherapy given both before and after surgery improve outcomes for patients with #GallbladderCancer (compared to chemo given only after surgery)? #ClinicalTrial EA2197/OPT-IN aims to find out. More info: bit.ly/EA2197 cc: Shishir K. Maithel Winship Cancer Institute of Emory University

EA2174 lead Jennifer Eads Penn Medicine - Abramson Cancer Center covers the findings. The trial added nivolumab to neoadjuvant chemoradiation for pts w esophageal/GEJ cancer. Insight = Further analysis is needed on how radiation impacts the efficacy of immune checkpoint inhibitors. youtube.com/watch?v=lAIQQL…

The Experimental Therapeutics Clinical Trials Network (#ETCTN) focuses on conducting early-stage trials of innovative #cancer treatment therapies. Learn more about disease portfolios and the status of trials—whether they are in review, approved, or active: buff.ly/2NxulU

S1900K is a new Lung-MAP sub-study that tests combining ramucirumab and tepotinib for non-small cell #lungcancer that has a SWOG.org/S1900K. Or call 1-800-4-CANCER. #lcsm #nsclc @GO2Foundation

Newly Activated #NCTN #HeadAndNeckCancer #ThyroidCancer Trial: (EA3231) A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em, led by ECOG-ACRIN Cancer Research Group Learn more: buff.ly/4eiwKyf

“Studying TAK-243 in Patients With Advanced Cancer (#ETCTN: 10299)”, is a new study for people with advanced #solidtumors, which may have metastasized, as well as for people with #lymphoma. Study is led by Dr. Sarah Shin of @NCITreatment #DTC. Learn more: buff.ly/3Te14lm

Newly Activated #NCTN #BrainCancer Trial (NRG-BN013): Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases, led by Dr. Rupesh Kotecha NRG Oncology Learn more: buff.ly/4dH88iC

The Pediatric Early Phase Clinical Trials Network (PEP-CTN) strives to enhance National Cancer Institute’s program for conducting early phase clinical trials in children with #cancer. Learn more about this #NCICTEP program: buff.ly/367DxuG #ChildhoodCancerAwarenessMonth #CCAM